Agnes Shanley

UBM Americas

Agnes Shanley is senior editor of Pharmaceutical Technology.


Bringing Six Sigma to Preclinical Pharma R&D

Branching out from roots in industrial biotechnology, Riffyn Data Systems (and its CEO Tim Gardner) is taking the message of data-driven process improvement to biopharma.

Investigating an OOS in a Biosafety Cabinet

Determining the root cause of out-of-specification (OOS) and other problems requires a careful, deductive approach and a clear understanding of processes.